The Claim

Among older adults with type 2 diabetes, frailty (Frailty Index >0.21) is associated with a 16% reduction in the benefit of intensive glucose control on combined macro- and microvascular events, as evidenced by a hazard ratio of 1.03 (95% CI 0.90–1.19) in frail individuals versus 0.84 (95% CI 0.74–0.94) in nonfrail individuals, indicating attenuation of the protective effect of aggressive glucose lowering in the presence of frailty.

Source: The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

In older adults with type 2 diabetes, those with frailty experience less protection from intensive glucose control against heart and kidney complications compared to those without frailty.

See the scientific wording

Among older adults with type 2 diabetes, frailty (defined by a Frailty Index >0.21) is associated with a 16% reduction in the benefit of intensive glucose control on combined macro- and microvascular events, with a hazard ratio of 1.03 (95% CI 0.90–1.19) in frail individuals compared to 0.84 (95% CI 0.74–0.94) in nonfrail individuals, indicating that the protective effect of aggressive glucose lowering is significantly attenuated in those with frailty.

Why this might work

In frail older adults with diabetes, muscle loss and organ decline make the body less able to handle strong blood sugar-lowering drugs. These drugs cause dangerous drops in blood sugar because the body can't respond properly, and the stress from low sugar damages blood vessels. This cancels out the benefit of lowering blood sugar to protect the heart and kidneys.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial

    In older adults with diabetes, tightly controlling blood sugar helps prevent heart and kidney problems—but this help is much weaker in people who are frail. The study shows frail people get almost no benefit from tight control and are more likely to have dangerous low blood sugar episodes.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.